跳至主要内容
临床试验/ACTRN12621000202864
ACTRN12621000202864尚未招募未知

The efficacy of middle meningeal artery embolisation as primary treatment for chronic subdural haematoma in adult patients

The Canberra Hospital0 个研究点目标入组 72 人开始时间: 2021年2月26日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patient aged 18 or above with a diagnosis of chronic subdural haematoma. A patient is considered stable (i.e. not requiring emergency surgical evacuation) if and only if they fit all of the following criteria:
  • 1. GCS => 13
  • 2. Lateralised weakness if present >= 4/5 power
  • 3. No other neurological deficits

排除标准

  • Significant contraindications to surgery or angiography (eg. renal failure and allergies)
  • Acute subdural haematoma
  • Chronic subdural haematoma related to an underlying pathology other than trauma

研究者

相似试验

The role of middle meningeal artery embolisation as... | 临床试验